Learning Objectives
Upon completion of this activity, participants will be better able to apply:
- Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment
- Study the interface between neurology and psychiatry
- Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode
- Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress and anxiety disorder
- Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing, and the postpartum period
- Review the appropriate use of medications in the treatment of sleep disorders
- Access psychopharmacologic treatment of eating disorders
- Summarize the interface between medicine and psychiatric disorders with an emphasis on cardiovascular disease and cancer
- Review the appropriate use of stimulants in the treatment of attention and ADHD disorders as well as their use as an adjunct to antidepressant treatment
- Identify psychopharmacologic treatment for the borderline personality disorder
- Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates, and cannabis
- Recognize when to utilize ECT and TMS for the treatment of depression
- Discuss standard psychopharmacologic treatments that have now been proven to be ineffective
- Give examples of the latest advances and problems associated with treatment approaches in the child, adolescent and geriatric populations
TOPICS / SPEAKERS:
- Neurobiology for the Practicing Clinician – Including Ketamine, Cannabinoids, Inflammation, and Hormones
Carl Salzman, MD
- Neuropsychiatry – Interface Between Neurological and Psychiatric Disorders
Martin A. Samuels, MD
- The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease
Charles B. Nemeroff, MD, PhD
- Pharmacological Treatment of Schizophrenia, Prodrome, First Episode, Relapse, and Recovery
Matcheri S. Keshavan, MD
- Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Samuels, Nemeroff, and Keshavan
- Latest Advances and Current Treatment of Bipolar Mania and Bipolar Depression
Ross J. Baldessarini, MD DSc (hon)
- Advances in Treatment for Refractory Depression
Alan F. Schatzberg, MD
- The Latest Tricks of the Trade – What to Do When Nothing Works in the Treatment of Resistant Psychiatric Disorders
Stephan M. Stahl, MD, PhD, DSc (hon)
- Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Baldessarini, Schatzberg, and Stahl
- Anxiety – Treat the Symptoms or Treat the Disorder When First Line Therapies Fail
Stephan M. Stahl, MD, PhD, DSc (hon)
- Evaluation and Pharmacological and CBT Treatment of Sleep Disturbance
John W. Winkelman, MD, PhD
- Effective Use of Stimulants in Psychiatry – Adult ADD, Anti-Depressant Augmentation, and Eating Disorders
John Ratey, MD
- Child and Adolescent Psychopharmacology – Current and Recent Pharmacologic Treatments
Barbara J. Coffey, MD, MS
- Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Winkelman, Sheehan, Ratey, and Coffe
- Pharmacological Treatment of Substance Use Disorders – Opioids, Alcohol and Marijuana
Roger D. Weiss, MD
- Use of Psychotropic Drugs in the Life Cycle of Women – PMS, Pregnancy, Lactation and Menopause
Ariadna Forray, MD
- Geriatric Psychopharmacology – What Every Prescriber Should Know About Treating the Elderly with Medications
Carl Salzman, MD
- Panel Discussion
Moderator – Carl Salzman, MD
Panel – Drs. Forray and Weiss
